Corvion, with a valuation of $56.53 million, is raising funds on StartEngine. It is a pre-clinical medical device company that has developed a next-generation Left Ventricular Assist Device (LVAD). Corvion’s LVAD is ready to disrupt the market and support patients with end-stage heart failure. The LVAD developed by Corvion uses wireless charging and is triple the efficiency of tethered models to free patients from power lines and bulky external systems. Greg Aber founded Corvion in July 2020. The current crowdfunding campaign has a minimum target of $14,999.25 and a maximum target of $1.23 million. The campaign proceeds will be used for product development, company employment, and operating expenses.